Integrated bioassays in microfluidic devices: botulinum toxin assays

Area of Science:

• Biotechnology
• Analytical Chemistry
• Biomedical Engineering

Background:

• Botulinum neurotoxin serotype A (BoNT-A) poses significant health risks, necessitating efficient screening methods.
• Current screening methods can be time-consuming and require large sample volumes.
• Microfluidic technology offers potential for miniaturized, high-throughput biological assays.

Purpose of the Study:

• To develop and validate a microfluidic assay for screening botulinum neurotoxin serotype A (BoNT-A).
• To demonstrate the system's capability for inhibitor screening and concentration-response analysis.
• To establish a versatile microfluidic platform adaptable for various biochemical assays.

Main Methods:

• Fabrication of molded silicone microdevices with integrated valves, pumps, and reagent reservoirs.
• Development of automated control hardware and software for assay protocol and data acquisition.
• Utilization of a fluorescent resonance energy transfer (FRET) assay with fluorescence microscopy for detection.

Main Results:

• Successful development and validation of a microfluidic assay for BoNT-A screening.
• Demonstrated feasibility with a peptide inhibitor, showing good agreement with macroscale experiments.
• The system's design allows for parallel assays, dilution series, and concentration-response data generation.

Conclusions:

• The developed microfluidic assay provides an accurate and efficient method for BoNT-A screening.
• The scalable and programmable nature of the chip enables high-throughput analysis.
• The microfluidic platform is versatile and can be adapted for a wide range of other biochemical assays.